
CAS 1467057-23-3
:Formule :C19H16ClNO3
InChI :InChI=1S/C19H16ClNO3/c20-16-9-17-14(15(10-21-17)18(22)23)8-13(16)11-2-4-12(5-3-11)19(24)6-1-7-19/h2-5,8-10,21,24H,1,6-7H2,(H,22,23)
Code InChI :FHQXLWCFSUSXBF-UHFFFAOYSA-N
SMILES :C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=C3)C(=CN4)C(=O)O)Cl)O
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
8 produits trouvés.
1H-Indole-3-carboxylic acid, 6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-
CAS :Formule :C19H16ClNO3Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :341.7882PF-06409577
CAS :6-Chloro-5-(4-(1-hydroxycyclobutyl)phenyl)-1H-indole-3-carboxylic acidFormule :C19H16ClNO3Degré de pureté :98%Masse moléculaire :341.79PF-06409577
CAS :PF-06409577 is an effective, orally active, and specific allosteric activator of AMPK (EC50: 7 nM, for α1β1γ1).Formule :C19H16ClNO3Degré de pureté :95.17% - 98.21%Couleur et forme :SolidMasse moléculaire :341.79Ref: TM-T4427
1mg34,00€2mg43,00€5mg63,00€1mL*10mM (DMSO)71,00€10mg100,00€25mg200,00€50mg334,00€100mg537,00€200mg762,00€PF 06409577
CAS :Potent agonist of a1β1γ1 5′-adenosine monophosphate-activated protein kinase (AMPK). It binds to the allosteric drug and metabolite (ADaM) site at the α- and β- subunit interface of AMPK. It has potential for the treatment of diabetic nephropathy. PF 06409577 reduces infections caused by flaviviruses, mediated by changes in the metabolism of lipids in host cells.
Formule :C19H16ClNO3Degré de pureté :Min. 95%Couleur et forme :White/Off-White SolidMasse moléculaire :341.79 g/mol6-CHLORO-5-(4-(1-HYDROXYCYCLOBUTYL)PHENYL)-1H-INDOLE-3-CARBOXYLIC ACID
CAS :Formule :C19H16ClNO3Degré de pureté :98%Masse moléculaire :341.79






